Treatment of fetal supraventricular tachycardia by intra-amniotic administration of digoxin.

Autor: López Ramón y Cajal, C., Couceiro Naveira, E., Piñón Mosquera, A., Gómez Mosquera, A.
Předmět:
Zdroj: Ultrasound in Obstetrics & Gynecology; Nov2019, Vol. 54 Issue 5, p698-699, 2p
Abstrakt: Supraventricular tachycardia (SVT) accounts for about 66-90% of cases of fetal tachyar rhythmia[2]. During the 24 h after transplacental treatment with maternal digoxin, we observed worsening of the fetal condition, including disappearance of amniotic fluid, absence of fetal movements and incessant SVT. We believe that this represents a new approach to the treatment of SVT when incomplete placental transmission is suspected or when there is a rapid deterioration in fetal condition warranting urgent therapy. [Extracted from the article]
Databáze: Complementary Index